This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
The Texas judge overseeing a patent infringement case filed by Invitrogen against Stratagene last week ordered Stratagene to post a supersedeas bond of $12.2 million to secure a portion of the $16.2 million judgment awarded to Invitrogen on Oct. 31, 2006.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.